Keyphrases
Monoclonal Antibody
100%
Theiler's murine Encephalomyelitis Virus
100%
CD70
100%
Theiler's murine Encephalomyelitis Virus-induced Demyelinating Disease
42%
Tumor Necrosis Factor-α
28%
Effector Phase
28%
Multiple Sclerosis
14%
Novel Therapeutics
14%
T Cell Activation
14%
Spleen
14%
Spinal Cord
14%
Clinical Treatment
14%
TNF Receptor 1 (TNFR1)
14%
B Cell Activation
14%
MRNA Level
14%
Demyelinating Diseases
14%
Ligation
14%
CD27
14%
Induction Period
14%
NK Cell Activity
14%
T Cell Expansion
14%
T Cell Survival
14%
Neuroscience
Monoclonal Antibody
100%
CD70
100%
Encephalomyelitis
100%
Demyelinating Disease
57%
Cell Activation
42%
Necrosis
28%
Multiple Sclerosis
14%
Tumor Necrosis Factor Receptor
14%
CD27
14%
Cell Survival
14%
Cell Expansion
14%
B Cell
14%
T Cell
14%
Natural Killer Cell
14%
Messenger RNA
14%
Immunology and Microbiology
Monoclonal Antibody
100%
Theiler's Murine Encephalomyelitis Virus
100%
CD70
100%
Clinically Isolated Syndrome
57%
Tumor Necrosis Factor
28%
Natural Killer Cell
14%
T Cell Activation
14%
B Cell Activation
14%
Cell Activation
14%
Multiple Sclerosis
14%
Spinal Cord
14%
Cell Survival
14%
Cell Expansion
14%
Tumor Necrosis Factor Receptor
14%
Immunology
14%